摘要
目的:对格拉司琼鼻喷雾剂在比格犬体内的药代动力学进行研究,评价其相对生物利用度。方法:比格犬采用随机、自身交叉给药,分别口服片剂、鼻腔给喷雾剂,用HPLC荧光方法测定格拉司琼血浆浓度。结果:比格犬分别单剂量口服片剂、鼻腔给喷雾剂2 mg后的主要药代动力学参数tmax分别为1.50±0.41和0.31±0.13 h,Cmax分别为6.45±1.15和11.93±1.33 ng.ml-1,AUC0-12分别为25.14±3.75和27.76±3.46 ng.h.ml-1,AUC0-∞分别为28.46±4.17和31.46±3.43 ng.h.ml-1,鼻喷雾剂对片剂的相对生物利用度为(111.9±18.9)%。结论:格拉司琼鼻喷雾剂比片剂吸收快,生物利用度较高。
AIM: To study the bioavailability of granisetron nasal spray in beagles. METHODS: A single 2 mg dose of granisetron tablet or nasal spray was given to beagles in a randomized crossover design. The drug plasma concentrations were determined by HPLC fluorescence method using bisoprolol fumarate as internal standard. RESULTS: The phannacokinetic parameters of granisetron tablet and nasal spray were as follow: tmax were 1.50 ±0.41 and 0.31±0.13 h, Cmax were 6.45±1.15 and 11.93 ± 1.33 ng. ml^-1, AUC0-12 were 25.14±3.75 and 27.76±3.46 ng.h.ml^-1 , AUCo-∞ were 28.46 ± 4.17 and 31.46 ± 3.43 ng. h. ml^-1, respectively. The mean relative bioavailability of nasal spray vs tablet was ( 111.88 ± 18.94) %. CONCLUSION: Gmnisetron nasal spray is readily absorbed and owns better bioavailability than the tablet.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2006年第3期270-272,共3页
Chinese Journal of Clinical Pharmacology and Therapeutics
基金
国家高技术研究发展计划(863)(№2003AA2Z347B)